Companies / Titan Pharmaceuticals Inc
Titan Pharmaceuticals Inc
TTNPTTNP.OBCIK 910267
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 21, 2023 | Lazar David E. CEO | Sell Open-market sale | Common Stock, par value $0.001 | $4.17M | -3.4M -100.00% | 0 | medium |
| Jun 21, 2023 | Lazar David E. CEO | Sell Open-market sale | Common Stock, par value $0.001 | $4.17M | -3.4M -100.00% | 0 | medium |
| Jul 6, 2022 | Lazar David E. CEO | Buy Open-market buy | Common Stock, par value $0.001 | $901.9K | +1.2M +82.05% | 2,587,108 | high |
| Jul 7, 2022 | Lazar David E. CEO | Buy Open-market buy | Common Stock, par value $0.001 | $739.0K | +744K +28.77% | 3,331,402 | high |
| Jun 21, 2023 | Lazar David E. CEO | Sell Open-market sale | Common Stock, par value $0.001 | $441.7K | -359K -100.00% | 0 | medium |
| Jun 21, 2023 | Lazar David E. CEO | Sell Open-market sale | Common Stock, par value $0.001 | $441.7K | -359K -100.00% | 0 | medium |
| Jul 6, 2022 | Lazar David E. CEO | Buy Open-market buy | Common Stock, par value $0.001 | $282.0K | +316K +732.23% | 359,066 | medium |
| Jan 24, 2023 | Lazar David E. CEO | Buy Open-market buy | Common Stock, par value $0.001 | $36.2K | +38K +1.13% | 3,368,902 | low |